Rhodanine–Sulfonate hybrids targeting aldose reductase: Synthesis, in vitro inhibition, molecular docking, and cytotoxicity studies
- 6 November 2025
- journal article
- research article
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (3) , 4385-4400
Abstract
Aldose reductase (ALR2), a key enzyme in the polyol pathway, plays a significant role in the onset and progression of diabetic complications, rendering it a critical pharmacological target. In this study, a novel series of twenty-four sulfonate ester-functionalized rhodanine derivatives (compounds 1–24) were rationally designed, synthesized via Knoevenagel condensation, and comprehensively evaluated for their inhibitory activity against ALR2. Spectroscopic and spectrometric methods confirmed the structural integrity of the synthesized compounds. In vitro enzyme inhibition assays revealed that all compounds acted as competitive inhibitors, with several analogues, particularly compounds 6 and 8, exhibiting stronger ALR2 inhibition (Ki = 0.43 µM and 0.48 µM, respectively) than the reference drug epalrestat (Ki = 0.98 µM). Structure–activity relationship (SAR) analysis highlighted the critical influence of para-substituted electron-donating (e.g., methyl) and electron-withdrawing (e.g., nitro, halogen) groups on binding potency. Molecular docking of the most potent inhibitor (compound 6) demonstrated a stable binding pose supported by key interactions, including hydrogen bonding with His110 and π–π stacking with Phe122. In silico ADME profiling confirmed favorable drug-likeness properties for all derivatives. Cytotoxicity studies on L929, A549, and RG-2 cell lines revealed that most compounds were less toxic than the reference drug at lower concentrations, with compound 8 showing a promising cytotoxic profile. These findings position rhodanine–sulfonate hybrids as promising scaffolds for the development of next-generation ALR2 inhibitors for the treatment of diabetic complications.Keywords
This publication has 44 references indexed in Scilit:
- A Brief Review on Different Reactions of RhodanineJournal of Heterocyclic Chemistry, 2024
- Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complicationsArchives of Biochemistry and Biophysics, 2024
- Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymesArchives of Biochemistry and Biophysics, 2024
- α‐Amylase Inhibitors Based on Thiazolidinone Skeleton: A Promising Approach in Diabetes ManagementChemistrySelect, 2023
- Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitorsDrug Development Research, 2023
- In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**ChemistrySelect, 2022
- N‐substituted phthalazine sulfonamide derivatives as non‐classical aldose reductase inhibitorsJournal of Molecular Recognition, 2022
- The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A reviewArchiv der Pharmazie, 2022
- Exploring sulfonate esters of 5-arylidene thiazolidine-2,4-diones as PTP1B inhibitors with anti-hyperglycemic activityMedicinal Chemistry Research, 2017
- Discovery of potential aldose reductase inhibitors using in silico docking studiesAdvances in Traditional Medicine, 2012